SIGA Technologies (NASDAQ:SIGA) Sees Large Volume Increase

SIGA Technologies, Inc. (NASDAQ:SIGA) shares saw unusually-high trading volume on Tuesday . Approximately 313,206 shares were traded during mid-day trading, a decline of 55% from the previous session’s volume of 691,356 shares.The stock last traded at $8.96 and had previously closed at $9.18.

SIGA Technologies Trading Up 2.4 %

The stock has a fifty day simple moving average of $8.28 and a 200-day simple moving average of $7.56. The stock has a market cap of $670.88 million, a price-to-earnings ratio of 8.35 and a beta of 0.94.

SIGA Technologies (NASDAQ:SIGA) last posted its quarterly earnings data on Thursday, August 1st. The company reported $0.03 earnings per share (EPS) for the quarter. SIGA Technologies had a return on equity of 51.40% and a net margin of 48.55%. The business had revenue of $21.81 million during the quarter. During the same quarter in the previous year, the business posted ($0.04) earnings per share. Sell-side analysts forecast that SIGA Technologies, Inc. will post 1.01 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of SIGA. AltraVue Capital LLC increased its holdings in SIGA Technologies by 6.6% during the 2nd quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock worth $16,528,000 after acquiring an additional 134,450 shares during the period. Denali Advisors LLC bought a new stake in SIGA Technologies in the second quarter valued at $1,815,000. Renaissance Technologies LLC boosted its holdings in SIGA Technologies by 404.1% in the second quarter. Renaissance Technologies LLC now owns 92,936 shares of the company’s stock worth $705,000 after acquiring an additional 74,500 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of SIGA Technologies by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 1,821,788 shares of the company’s stock worth $13,826,000 after buying an additional 133,883 shares in the last quarter. Finally, WINTON GROUP Ltd bought a new stake in SIGA Technologies in the 2nd quarter worth about $1,052,000. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.